Sign in

Priya Garg

@priyagargiddoc.bsky.social
1.1K followers 414 following 38 posts

Infectious Diseases Physician. Clinician Researcher. Immunocompromised Host ID. Transplant ID. @pmcc @ncic @wslhd Music lover, keen photographer and proud girl mum. #MedSky #TxID #WomeninSTEM #IDSky #InfectionPrevention #IDOnc

PostsRepliesMedia
Priya Garg @priyagargiddoc.bsky.social · 10/12/2025
🔍 Pleased to report our sub-cohort analysis of the INTERACT study evaluating IPC and surveillance practice in Australasian solid-organ transplant recipients has just been published in Transplant-ID! doi.org/10.1111/tid.... #TxID @ncicancer.bsky.social @thetxidjournal.bsky.social
doi.org
Infection Prevention and Surveillance in the Care of Australasian Solid‐Organ Transplant Recipients
This is the first survey of infection prevention/surveillance practice in the care of the Australasian solid-organ transplant population, demonstrating multiple key areas of heterogeneity and highlig...
010
Reposted by Priya Garg
The Medical Journal of Australia @mja.com.au · 05/02/2025
🔔 NEW in the Medical Journal of Australia Prolonged SARS‐CoV‐2 shedding in a lung transplant recipient: time for flexibility in infection prevention? ✍️ Alyssa Pradhan, David Pham, Alexander Brennan, Jen Kok and Priya Garg OPEN ACCESS buff.ly/42yLhDb
022
Reposted by Priya Garg
NCICancer @ncicancer.bsky.social · 05/09/2025
Australia’s first multi-site study of infections in cancer & transplant patients, PROSPER, is now published in BMJ Open! It will guide future infection prevention & control for this vulnerable group. Read the full article here: bmjopen.bmj.com/content/15/7...
011
Reposted by Priya Garg
Michelle Yong @michyong.bsky.social · 01/09/2025
🔥🔥Just published in #CID world-first clinical trial of IFN-a nasal spray vs placebo reduced #COVID 🦠 incidence 📉 by 40% in cancer pts. Well tolerated, safe, effective… Full link here: academic.oup.com/cid/advance-ar…
1173
Priya Garg @priyagargiddoc.bsky.social · 28/08/2025
Always exciting to learn more about novel cellular therapies for IFIs at Westmead Hospital ID week! (And see all the research across the precinct) @westmeadinst.bsky.social #TxID
230
Priya Garg @priyagargiddoc.bsky.social · 12/08/2025
Pleased to publish the INTERACT study - describing current infection prevention & surveillance practice in the care of Australasian cancer/transplant patients & areas for future research (& thankful to all who participated) 🌟 @ncicancer.bsky.social #TxID #IDSky www.ajicjournal.org/article/S019...
ajicjournal.org
The INTERACT study: Infection prevention and surveillance practice in the care of the Australasian cancer and transplant population
Australasian cancer and transplant populations are expanding, with increased infection risk related to prolonged survivorship and broader use of novel immunosuppressants. To optimise care, standardise...
4135
Reposted by Priya Garg
Chelsea Gorsline, MD 🦠🍄 @chelseagorsline.bsky.social · 25/11/2024
Our new @txidfellows.bsky.social paper is out! This one on ASP in #TxID. Practical tips for beginners and early career faculty. @courtharrismd.bsky.social @rebeccakumar.bsky.social @divsharma.bsky.social @mirandapharmdmph.bsky.social @hannah-imlay.bsky.social
33311
Reposted by Priya Garg
Ben Teh @benwteh.bsky.social · 08/08/2025
Delighted to have been part of these important ECiL-10 c diff guidelines specific to our haematology patients. #TxID @ncicancer.bsky.social @ichs-global.bsky.social @theebmt.bsky.social www.sciencedirect.com/science/arti...
smex-ctp.trendmicro.com
ScienceDirect.com | Science, health and medical journals, full text articles and books.
121
Reposted by Priya Garg
TransplantID.Net - American Society of Transplantation @transplantidnet.bsky.social · 01/07/2025
.@astct.bsky.social has #ID #HSCT #CAR-T guidelines in TCT Journal transplantid.net "GUIDELINES"▶️ "ASTCT Guidelines"📁 #️⃣ 9️⃣ : Mgmt of HHV-6B after HSCT and CAR-T Bonus: Tests for chromosomal integration! Thanks Aneela Majeed @clevelandclinic.bsky.social! transplantid.net/37V7X3QT
011
Priya Garg @priyagargiddoc.bsky.social · 01/08/2025
Excited to see what the PROSPER study (point prevalence of infections in cancer & transplant) demonstrates.. @ncicancer.bsky.social 🦠 @bmj.com #TxID #IDSky #EpiSky
bmjopen.bmj.com
Estimating the prevalence of key healthcare-associated and opportunistic infections in Australian transplant and cancer populations: protocol for the PROSPER point prevalence study
Introduction The immunocompromised host (ICH) is at increased risk for a range of opportunistic and healthcare-associated infections (OI/HAIs). With increased use of novel therapeutics and prolonged s...
030
Reposted by Priya Garg
NCICancer @ncicancer.bsky.social · 27/06/2025
We were proud to be well represented at the inaugural The Transplantation Society of Australia and New Zealand Infectious Disease Day on 20 June 2025 — a fantastic event co-badged with ASID Immunocompromised Host Special Interest Group.
031
Priya Garg @priyagargiddoc.bsky.social · 22/06/2025
Pleased to present our subgroup analysis @TSANZ. Would IPC specific to the SOT cohort be valuable? Which HAIs/OIs should we monitor, and how do we build a national framework for success? @ncicancer.bsky.social #TxID #IDSky
1102
Priya Garg @priyagargiddoc.bsky.social · 20/06/2025
Always a pleasure to hear @aussiedocwolfe.bsky.social speak on advances in organ transplantation & thankful to chair a session on infection surveillance in transplant @TSANZ Transplant Infectious Disease day! Congrats to the committee for putting together an exciting inaugural meeting.
250
Reposted by Priya Garg
Violet Zhu @vzhu1.bsky.social · 22/05/2025
Happy Infectious Diseases Pharmacists Day to my colleagues, mentors, and clinician-researcher heroes #IDPharmacistsDay #SIDPAdvocacy @adphaau.bsky.social @sidpharm.bsky.social @ncicancer.bsky.social
2236
Priya Garg @priyagargiddoc.bsky.social · 15/05/2025
Grateful to have received a travel stipend to spend an exciting few days at the @fredhutch.bsky.social ICH Symposium in Seattle, present & learn from experts in the field- Including @kottonnelson.bsky.social, Jay Fishman & our own @ncicancer.bsky.social @michyong.bsky.social, Monica Slavin & more..!
1112
Reposted by Priya Garg
Ilan Schwartz @germhuntermd.bsky.social · 09/05/2025
Herpes Simplex Virus and Drug Resistance - Comprehensive Update on Resistance Mutations and Implications for Clinical Management: A Narrative Review Open Access @cmijournal.bsky.social www.clinicalmicrobiologyandinfection.com/article/S119... #IDSky #TxID
Figure 1 Overview of mechanisms of action of different drugs used in the treatment of infection with HSV-1/2. The nucleoside analogues ACV, PCV and BVDU are phosphorylated by viral TK. ACV-P, PCV-P, BVDU-P and CDV are biphosphorylated by cellular kinases. The phosphorylated compounds are then incorporated into nascent DNA. This leads to a stop in viral replication or, in case of BVDU, destabilizes the DNA and inhibits the replication. FOS inhibits replication by directly binding POL and inhibiting the pyrophosphate binding site competitively. AMNV and PTV bind to the viral helicase-primase complex. This inhibits DNA unwinding and therefore inhibits replication. ACV: aciclovir; PCV: penciclovir; BVDU: brivudine; CDV: cidofovir; FOS: foscarnet; AMNV: amenamevir; PTV: pritelivir.
1209
Reposted by Priya Garg
Ilan Schwartz @germhuntermd.bsky.social · 26/04/2025
Cryptococcal Meningitis Treatment Beyond HIV: Recognizing the need for Individualized Immune-Based Strategies Hyunah Yoon, Liise-anne Pirofsky, @drboulware.bsky.social In non-HIV-associated CM, ⬇️ing immunosuppression --> ⬆️ inflammation --> 🧠 damage. academic.oup.com/cid/advance-... #TxID #IDSky
A line graph illustrating immunosuppressive drug intensity and immune cell recovery (CD4+ T, B and NK cells) over months following kidney transplantation, highlighting a window of heightened cryptococcal disease risk.Two parabola diagrams comparing HIV-associated cryptococcal damage and non-HIV transplant-associated damage. In both settings, too little or too much immune response can result in host damage (left and right arms of the parabola). However, in non-HIV transplant patients, the overall position on the parabola is less predictable, due to the heterogeneous effects of immunosuppressive medications before and during cryptococcal infection.
12110
Reposted by Priya Garg
Infection Control & Hospital Epidemiology @ichejournal.bsky.social · 22/04/2025
New from @loukasmd.bsky.social et al: Authors provide systematic review of pathogens & sources of contamination linked to outbreaks in HSCT units ▶️ 39 studies, various sources including water, construction, contamination #IDSky 📄: doi.org/10.1017/ice....
035
Reposted by Priya Garg
Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 12/04/2025
The most anticipated RCT in ID 🔥SNAP RCT🔥The largest RCT 2 date in SA bactermia N:1341 Cefazolin Vs ASPs ((flu)cloxacillin) for MSSA bacteremia Cefazolin is non-inferior (90d mortality)& less AKI than ASPs A practice-changer RCT that must change the guidelines #ESCMIDGlobal #IDSky
27021
Reposted by Priya Garg
NCICancer @ncicancer.bsky.social · 04/04/2025
Day 2 of the Australasian Society for Infectious Diseases (ASID) ASM in Canberra, our incredible NCIC team proudly showcased their poster presentations. It was a fantastic opportunity to showcase their hard work and dedication to advancing the ICH space on a national stage!
051
Priya Garg @priyagargiddoc.bsky.social · 04/04/2025
Great to hear work by my friend, fellow ID physician & PhD candidate @dremmalouise.bsky.social & nursing student Jobe Bonney on tackling TB in remote communities at the ASID ASM - excited to hear how the REACT project progresses! @asidaud.bsky.social
030
Priya Garg @priyagargiddoc.bsky.social · 04/04/2025
Honoured to speak & present our @ncicancer.bsky.social work on infection prevention in cancer/transplant at the Australasian Society of ID ASM with @nikhil-singh.bsky.social @michyong.bsky.social @benwteh.bsky.social, & amazing to hear & see the incredible work done at other centres nationally 👏🏽
282
Reposted by Priya Garg
NCICancer @ncicancer.bsky.social · 04/04/2025
Great 1st day at Australasian Society for Infectious Diseases meeting! @michyong.bsky.social led an insightful CMV symposium @benwteh.bsky.social chaired the "What's New in.." session as part of ICHSIG @priyagargiddoc.bsky.social comprehensive talk on key developments and gaps in the ICHS space
052
Priya Garg @priyagargiddoc.bsky.social · 14/03/2025
Sad to have had my last ‘in-person’ day as a physician at the @petermaccc.bsky.social, Melbourne! A fantastic place to practice, be inspired in #IDOnc #TxID and surrounded by #womeninSTEM! Will continue my PhD through the @ncicancer.bsky.social though, so many more return visits to come 🙌🏽
391
Priya Garg @priyagargiddoc.bsky.social · 12/03/2025
Excited to receive some @ucla-id-fellowship.bsky.social merch in the post here in Melbourne to use on my next ward round! UCLA Transplant-ID; thank you again- a fabulous team & such great learnings/ collaborative discussions in the care of the high-risk ICH @jschaenmanmd.bsky.social #TxID #IDsky
1110
Reposted by Priya Garg
Pharmageddon @pharmageddon.bsky.social · 26/02/2025
Next draft Infection Card for Epipocalypse: Bug Detectives: Measles! Unfortunately this is a thing again. Remember the 3 C's and to keep it in your differential! #IDSky #MedSky #EpiSky any feedback or suggestions?
Measles.
032
Reposted by Priya Garg
NCICancer @ncicancer.bsky.social · 03/02/2025
On #WorldCancerDay, we honor those affected by cancer and highlight the EINSTEIN project, which aims to revolutionize infection detection in immunocompromised cancer patients. EINSTEIN uses AI and medical records to detect infections early. Learn more: cancerandinfections.org/infection-su...
021
Priya Garg @priyagargiddoc.bsky.social · 02/02/2025
Really interesting paper by my colleagues at @domucla.bsky.social - and fits with my own thoughts about the utility/pitfalls of plasma mcfDNA (including low yield of fungal pickup) as well as giving some ideas for future diagnostic stewardship if incorporated into practice @jschaenmanmd.bsky.social
cambridge.org
Real-world clinical impact of plasma cell-free DNA metagenomic next-generation sequencing assay | Infection Control & Hospital Epidemiology | Cambridge Core
Real-world clinical impact of plasma cell-free DNA metagenomic next-generation sequencing assay
2102
Reposted by Priya Garg
Ben Teh @benwteh.bsky.social · 16/01/2025
Practice affirming results from our team @victoriahall.bsky.social @ncicancer.bsky.social - No additional benefit from second influenza vaccine dose/adjuvant vaccines in non-HCT haematology patients. #TxID #IDsky #medsky www.nejm.org/doi/full/10....
nejm.org
Influenza Vaccination Strategies in Patients with Hematologic Cancer | NEJM
In this trial involving patients with hematologic cancers, the immune responses that were elicited were similar for adjuvanted-dose and standard-dose influenza vaccines.
0177
Reposted by Priya Garg
Josh Davis @gurujosh.bsky.social · 23/12/2024
It's that time of year again. Here are my top 10 ID papers of 2024 1. My opinion 2. Practice changing, paradigm-shifting or dogma challenging 3. Not COVID 4. Alphabetical order by first author 5. CoI for 4 and 5 (I am an author) Summary slide here, details in thread #IDSky #Top10IDpapers
1110236
Reposted by Priya Garg
Antibiotic Steward 🅱️C🆔🅿️🌟 @absteward.bsky.social · 11/12/2024
🔥🔥 NEW 🔥🔥 Year In Review: Top Infectious Diseases Articles From 2024 Our new post, a great collaboration with my friend 🌟 @idstewardship.bsky.social 1️⃣6️⃣⚡️🆔 RCTs 7️⃣Syst Reviews/Meta 3️⃣🌏Guidelines ✨️Wiki_Guidelines #idsky #EMIMCC #medsky #utisky EnJoy Share plz! www.idstewardship.com/year-review-...
idstewardship.com
Year In Review: Top Infectious Diseases Articles From 2024
In this article a selection of notable peer-reviewed publications from 2024 are provided. Article Selection by: Bassam Ghanem, Pharm.D., MS, BCPS Article Construction by: Timothy P. Gauthier, Pharm.D....
1012052
Priya Garg @priyagargiddoc.bsky.social · 10/12/2024
Prolonged COVID-19 shedding in complicated lung transplant patient - a tricky case for us to navigate at the time! Interested in whether de-isolation policies have since changed at other centres? #IDSky #TxID @alyssapradhan.bsky.social onlinelibrary.wiley.com/doi/10.5694/...
onlinelibrary.wiley.com
Prolonged SARS‐CoV‐2 shedding in a lung transplant recipient: time for flexibility in infection prevention?
Click on the article title to read more.
151
Reposted by Priya Garg
Maricar Malinis @maricarmalinis.bsky.social · 16/11/2024
The TTS-TID are always on the look out for interesting and challenging Transplant ID cases. Please submit your case for consideration onlinelibrary.wiley.com/page/journal...
21710
Reposted by Priya Garg
Josh Davis @gurujosh.bsky.social · 21/11/2024
Hi #IDSky! I’m putting together my usual top 10 ID papers of this year list again (this time will post here not in the other world). Please tell me your candidate papers - practice changing paradigm shifting or dogma challenging!
209117
Priya Garg @priyagargiddoc.bsky.social · 17/11/2024
A delayed shout out to UCLA Transplant ID & wonderful @jschaenmanmd.bsky.social for recently hosting me on the wards @RonaldReagancentre LA, letting me ask a thousand questions & share my ICH research. Fantastic clinical cases & team! Sharing helps with caring! #IDSky #TxID @ncicancer.bsky.social
1130
Priya Garg @priyagargiddoc.bsky.social · 15/11/2024
Had a great time attending my first Melbourne ‘Forbes Week’ at the PMCC where we hosted @kottonnelson.bsky.social as the 39th Forbes Fellow! Fantastic to have a few days of solid ICH-ID learning across 3 local sites. Well done to @bradgardiner.bsky.social and organisers! 🙌🏽 #TxID
2111
Priya Garg @priyagargiddoc.bsky.social · 13/11/2024
Delighted to be early to the party (for once)! #IDSky #MedSky ID Physician and clinician researcher in Melbourne, interested in Transplant-ID, Immunocompromised Host, Tropical Med & Infection Prevention. Excited to join the @bsky.app ID community 💪
2402